CV Sciences, Inc. Operating Income Loss

• CV Sciences, Inc. showed an increase of +78.5% in Operating Income Loss from 2024 to 2025.
• This data is from CV Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2012 to 2025), CV Sciences, Inc.'s Operating Income Loss has declined by 992.6%.
• Historical annual values: Fiscal year 2025: -$470.0 thousand | Fiscal year 2024: -$2.19 million | Fiscal year 2023: $3.36 million | Fiscal year 2022: -$6.85 million | Fiscal year 2021: -$18.45 million | Fiscal year 2020: -$22.59 million | Fiscal year 2019: -$17.24 million | Fiscal year 2018: $10.25 million | Fiscal year 2017: -$4.86 million | Fiscal year 2016: -$13.07 million | Fiscal year 2015: -$11.21 million | Fiscal year 2014: -$8.55 million | Fiscal year 2013: -$1.62 million | Fiscal year 2012: -$43.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026